ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -5.73%-406K | 28.65%-386K | 14.50%-613K | -82.64%-2.6M | -123.08%-957K | -284.00%-384K | 25.07%-541K | -50.00%-717K | 39.52%-1.42M | 55.59%-429K |
Net income from continuing operations | -148.74%-1.65M | 26.95%-2.92M | 58.39%-1.37M | 24.46%-7.76M | 20.29%-3.84M | 267.87%3.38M | -95.03%-4M | -137.21%-3.3M | -117.45%-10.27M | -205.46%-4.81M |
Operating gains losses | ---- | ---- | ---- | ---477K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -43.59%22K | 500.00%18K | 15.79%22K | -15.38%88K | 8.00%27K | 105.26%39K | -85.00%3K | -52.50%19K | -15.45%104K | -28.57%25K |
Unrealized gains and losses of investment securities | -118.18%-2K | --0 | 400.00%15K | -50.00%10K | 87.50%-1K | -62.07%11K | -142.86%-3K | 137.50%3K | 1,100.00%20K | -104.60%-8K |
Remuneration paid in stock | 26.98%80K | 188.00%216K | -73.08%21K | -36.24%241K | -70.59%25K | -68.97%63K | 102.70%75K | 47.17%78K | -31.52%378K | -38.41%85K |
Other non cashItems | 129.02%1.17M | -29.43%2.24M | -67.00%915K | -35.19%5.25M | -26.48%3.32M | -374.91%-4.02M | 144.43%3.18M | 238.17%2.77M | 213.91%8.1M | 544.22%4.52M |
Change In working capital | -117.36%-25K | -71.57%58K | 26.39%-212K | -81.74%44K | 93.22%-16K | -28.00%144K | 70.00%204K | -281.13%-288K | 127.23%241K | 46.24%-236K |
-Change in receivables | -36.17%30K | -101.33%-1K | 900.00%376K | -302.63%-153K | -221.13%-228K | -31.88%47K | 725.00%75K | -113.64%-47K | -72.73%-38K | -244.90%-71K |
-Change in prepaid assets | 150.00%13K | -87.50%-15K | -28.95%-49K | -115.32%-17K | -68.02%55K | -170.27%-26K | 69.23%-8K | 47.22%-38K | 193.28%111K | 243.33%172K |
-Change in payables and accrued expense | -155.28%-68K | -45.99%74K | -165.52%-539K | 27.38%214K | 146.59%157K | 30.85%123K | -13.29%137K | -180.24%-203K | 122.58%168K | 8.42%-337K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -5.73%-406K | 28.65%-386K | 14.50%-613K | -82.64%-2.6M | -123.08%-957K | -284.00%-384K | 4.42%-541K | -118.60%-717K | 39.52%-1.42M | 55.59%-429K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 168.14%308K | 102.47%63K | 105.70%91K | 12.87%-7.87M | 33.32%-3.27M | 65.60%-452K | -19.02%-2.55M | -137.65%-1.6M | -201.47%-9.04M | -570.86%-4.9M |
Net PPE purchase and sale | 8.49%-291K | ---450K | ---546K | -406.59%-2.08M | -329.02%-1.76M | ---318K | --0 | --0 | ---410K | ---410K |
Net business purchase and sale | --0 | ---- | ---- | 102.60%91K | 100.04%1K | --90K | ---- | ---- | -250.00%-3.5M | ---2.5M |
Net other investing changes | 367.41%599K | 120.09%513K | 139.89%637K | -14.85%-5.89M | 24.17%-1.51M | 82.95%-224K | -122.97%-2.55M | -137.65%-1.6M | -156.63%-5.13M | -172.78%-1.99M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 168.14%308K | 102.47%63K | 105.70%91K | 12.87%-7.87M | 33.32%-3.27M | 65.60%-452K | -19.02%-2.55M | -137.65%-1.6M | -201.47%-9.04M | -570.86%-4.9M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -16.93%417K | -94.70%110K | 125.36%70K | -40.48%8.06M | -36.30%5.75M | -67.92%502K | -25.04%2.08M | -265.27%-276K | 139.56%13.53M | 242.81%9.03M |
Net issuance payments of debt | 0.00%-18K | 50.00%-19K | -12.50%-27K | -67.40%3.9M | -66.97%3.98M | 45.45%-18K | -58.33%-38K | 20.00%-24K | 328.47%11.96M | 22,835.85%12.05M |
Net common stock issuance | --0 | --0 | ---1K | -51.26%1.3M | 13,070.00%1.3M | --0 | --0 | --0 | 8.17%2.66M | -100.41%-10K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -15.19%134K | -82.91%27K |
Interest paid (cash flow from financing activities) | --0 | --0 | --0 | -86.12%-778K | 91.87%-34K | --0 | ---374K | ---370K | ---418K | ---418K |
Net other financing activities | -16.35%435K | -94.81%129K | -16.95%98K | 550.56%3.64M | 119.53%511K | -65.88%520K | 2,224.30%2.49M | -33.71%118K | -437.66%-807K | -3,837.14%-2.62M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -16.93%417K | -94.70%110K | 125.36%70K | -40.48%8.06M | -36.30%5.75M | -67.92%502K | -25.04%2.08M | -265.27%-276K | 139.56%13.53M | 242.81%9.03M |
Net cash flow | ||||||||||
Beginning cash position | 26.45%153K | -75.93%286K | -83.12%637K | 302.24%3.77M | 166.18%181K | -14.18%121K | 1,621.74%1.19M | 302.24%3.77M | 24.07%938K | -30.61%68K |
Current changes in cash | 195.51%319K | 79.10%-213K | 82.55%-452K | -178.57%-2.42M | -58.73%1.53M | -321.19%-334K | -1,887.72%-1.02M | -210.92%-2.59M | 928.43%3.08M | 294.46%3.7M |
Effect of exchange rate changes | -148.22%-190K | 266.67%80K | 1,920.00%101K | -200.00%-720K | -21,520.00%-1.07M | 275.89%394K | -420.00%-48K | 113.89%5K | -105.13%-240K | 105.10%5K |
End cash Position | 55.80%282K | 26.45%153K | -75.93%286K | -83.12%637K | -83.12%637K | 166.18%181K | -14.18%121K | 1,621.74%1.19M | 302.24%3.77M | 302.24%3.77M |
Free cash from | 0.71%-697K | -54.53%-836K | -61.65%-1.16M | -155.10%-4.68M | -223.72%-2.72M | -602.00%-702K | 4.42%-541K | -118.60%-717K | 22.10%-1.83M | 13.15%-839K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.